Eli Lilly (United States)
In research, Eli Lilly (United States) stands highest in Medicine (#548 of 10,443 worldwide), Endocrinology, Diabetes and Metabolism (#14 of 261 worldwide) and Health Sciences (#686 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism, Statistics and Probability and Psychiatry and Mental health — Endocrinology, Diabetes and Metabolism is 18.0× its share of world research.
- World rank, 2022–2025
- #1,662 of 28,054 · #818 all time
- Rank in United States
- #258 of 4,192
- Research works
- 15k ▼ 15% vs 2013–17
- Citations
- 598k 40.0 per fractional work
- Top-10% rate
- 22.1% record average 16.5%
- Open access
- 28% world 28%
What is Eli Lilly (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #548 of 10,443 | 24.0% | 649 | #290 | |
| Endocrinology, Diabetes and MetabolismSubfield | #14 of 261 | 28.1% | 113 | #45 | |
| Health SciencesDomain | #686 of 11,982 | 24.1% | 676 | #373 | |
| Life SciencesDomain | #990 of 7,800 | 22.4% | 268 | #365 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,537 of 3,579 | 21.8% | 165 | #434 | |
| PhysiologySubfield | #276 of 548 | 21.9% | 66 | #189 | |
| Physical SciencesDomain | #6,669 of 12,888 | 14.3% | 145 | #2504 | |
| Molecular BiologySubfield | #1,168 of 2,175 | 20.2% | 101 | #332 | |
| Social SciencesDomain | #7,927 of 10,521 | 17.6% | 66 | #3217 |
Each strip is that field’s whole ranked pool, with the notch where Eli Lilly (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#290 #548
- Endocrinology, Diabetes and Metabolism#45 #14
- Health Sciences#373 #686
- Life Sciences#365 #990
- Biochemistry, Genetics and Molecular Biology#434 #1,537
- Physiology#189 #276
- Physical Sciences#2,504 #6,669
- Molecular Biology#332 #1,168
- Social Sciences#3,217 #7,927
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Eli Lilly (United States) specialise in?
Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 18.0× the share of its output that it takes of world research.
- Endocrinology, Diabetes and MetabolismSubfield · 112.5 works18×
- Statistics and ProbabilitySubfield · 36.3 works15×
- Psychiatry and Mental healthSubfield · 48.1 works8.3×
- DermatologySubfield · 23.1 works7.6×
- RheumatologySubfield · 38.3 works7.2×
- PhysiologySubfield · 65.6 works6.5×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.4×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.4×
- Immunology and Microbiology 4.3×
- Medicine 2.9×
- Mathematics 2.7×
- Biochemistry, Genetics and Molecular Biology 2.7×
- Veterinary 2.0×
- Chemistry 1.7×
- Neuroscience 1.5×
- Economics, Econometrics and Finance 1.3×
- Decision Sciences 0.8×
- Health Professions 0.7×
- Nursing 0.4×
- Chemical Engineering 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Engineering 0.2×
- Materials Science 0.2×
- Environmental Science 0.1×
- Dentistry 0.1×
- Business, Management and Accounting 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Eli Lilly (United States)?
Ranked on the composite score, Eric Siemers, Sergey Shcherbinin and Steven Wrighton lead among researchers whose main affiliation is Eli Lilly (United States).
- 1 Eric Siemers United States · #17,755 worldwide 1.4k citations · 40 works
- 2 Sergey Shcherbinin United States · #33,532 worldwide 382 citations · 36 works
- 3 Steven Wrighton United States · #38,249 worldwide 515 citations · 33 works
- 4 Paula T. Trzepacz United States · #41,575 worldwide 256 citations · 35 works
- 5 John R. Sims United States · #58,906 worldwide 392 citations · 29 works
- 6 Brandy R. Matthews United States · #67,677 worldwide 210 citations · 37 works
- 7 Gerald B. Grindey United States · #76,300 worldwide 351 citations · 31 works
- 8 Charles M. Beasley United States · #77,703 worldwide 248 citations · 33 works
- 9 Amit Aggarwal United States · #78,788 worldwide 198 citations · 33 works
- 10 Gary D. Tollefson United States · #81,306 worldwide 193 citations · 34 works
Which keywords describe research at Eli Lilly (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Diabetes, Type 2 Diabetes, Obesity, Heart Failure, Cardiovascular Disease and Biomarkers.
- Therapeutic Strategies
- Atherosclerosis
- Immunology
- Continuous Glucose Monitoring
- Neuroimaging
- Biopharmaceuticals
- Therapeutic Antibodies
- Neurodegeneration
- Cardiovascular Risk
- Weight Loss
- Neurological Disorders
- Alzheimer's Disease
- Glucose Control
- Metabolic Syndrome
- Clinical Guidelines
- Biomarkers
- Obesity
- Cardiovascular Disease
- Inflammation
- Glycemic Control
- Epidemiology
- Insulin Therapy
- Diabetes
- Type 2 Diabetes
- Heart Failure
- Oxidative Stress
- Monoclonal Antibodies
- Cardiovascular Outcomes
- Quality of Life
- Genetics
- Neuroinflammation
- Inflammatory Bowel Disease
- Clinical Trials
- Type 1 Diabetes
- Complications
- Immunogenicity
- Autoantibodies
- Hypoglycemia
- Lifestyle Intervention
- Glycosylation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology90▲ 1.98×72 topics
- Glycemic Control90▲ 50×4 topics
- Insulin Therapy80▲ 57×3 topics
- Inflammation75▲ 3.1×66 topics
- Diabetes68▲ 12×17 topics
- Cardiovascular Disease67▲ 5.2×31 topics
- Type 2 Diabetes62▲ 24×5 topics
- Obesity61▲ 7.0×19 topics
- Heart Failure58▲ 12×12 topics
- Biomarkers54▲ 6.9×16 topics
- Oxidative Stress51▲ 2.7×42 topics
- Clinical Guidelines50▲ 15×8 topics
- Monoclonal Antibodies47▲ 45×3 topics
- Metabolic Syndrome47▲ 5.0×19 topics
- Cardiovascular Outcomes46▲ 73×1 topic
- Glucose Control46▲ 73×1 topic
- Quality of Life44▲ 2.6×33 topics
- Alzheimer's Disease43▲ 13×8 topics
- Genetics40▲ 5.0×17 topics
- Neurological Disorders40▲ 6.1×18 topics
- Neuroinflammation39▲ 12×6 topics
- Weight Loss38▲ 20×4 topics
- Inflammatory Bowel Disease37▲ 28×5 topics
- Cardiovascular Risk36▲ 10×9 topics
- Clinical Trials36▲ 4.7×15 topics
- Neurodegeneration34▲ 9.8×8 topics
- Type 1 Diabetes34▲ 35×2 topics
- Therapeutic Antibodies34▲ 42×2 topics
- Complications32▲ 5.5×9 topics
- Biopharmaceuticals30▲ 51×3 topics
- Immunogenicity30▲ 60×3 topics
- Neuroimaging29▲ 9.3×8 topics
- Autoantibodies29▲ 11×8 topics
- Continuous Glucose Monitoring28▲ 52×1 topic
- Hypoglycemia28▲ 52×1 topic
- Immunology27▲ 22×2 topics
- Lifestyle Intervention26▲ 27×2 topics
- Atherosclerosis26▲ 7.8×11 topics
- Glycosylation25▲ 20×3 topics
- Therapeutic Strategies25▲ 23×2 topics
Which research topics does Eli Lilly (United States) publish most on?
By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Alzheimer's disease research and treatments and Dementia and Cognitive Impairment Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 46 works
- 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 28 works
- 3 Alzheimer's disease research and treatments Physiology 25 works
- 4 Dementia and Cognitive Impairment Research Psychiatry and Mental health 24 works
- 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 24 works
- 6 Inflammatory Bowel Disease Genetics 22 works
- 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 18 works
- 8 Statistical Methods in Clinical Trials Statistics and Probability 18 works
- 9 Dermatology and Skin Diseases Dermatology 16 works
- 10 Migraine and Headache Studies Psychiatry and Mental health 16 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Eli Lilly (United States)'s research output changed?
Output in 2018–2022 was 15% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Indianapolis
- Indiana University – Purdue University Indianapolis
- University of Indianapolis
- Butler University
- Indiana University Health
- Indianapolis Zoo
- Riley Hospital for Children
- Methodist Hospital
- Martin University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.